Macter International Limited (PSX:MACTER)

Pakistan · Delayed Price · Currency is PKR

233.38

-4.62 (-1.94%)

At close: Nov 6, 2026

Market Cap	10.69B -32.4%
Revenue (ttm)	12.50B +14.1%
Net Income	628.35M -24.7%
EPS	13.71 -24.7%
Shares Out	45.81M
PE Ratio	17.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,574
Open	236.00
Previous Close	238.00
Day's Range	230.00 - 239.10
52-Week Range	220.00 - 374.99
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Macter International

Macter International Limited, a contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan. It offers Upacnet, Indyco M, Digebro Syrup, and SEGLUTIDE. The company provides pharmaceutical products in the areas of antibiotics, anti-allergy, cardiovascular, anti-viral, etc.; and consumer and biological products. It also offers solid and liquid oral dosage forms, such as tablets, capsules, syrups, suspensions, and dry powders. In addition, the company provides injections, including ... [Read more]

Industry Pharmaceuticals

Sector Healthcare

Founded 1992

Employees 1,449

Stock Exchange Pakistan Stock Exchange

Ticker Symbol MACTER

Full Company Profile

Financial Performance

In fiscal year 2026, Macter International's revenue was 12.17 billion, an increase of 17.46% compared to the previous year's 10.36 billion. Earnings were 679.42 million, a decrease of -12.49%.

Financial Statements